What are the criteria for diagnosing cardiogenic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Criteria for Cardiogenic Shock

Cardiogenic shock requires BOTH sustained hypotension (systolic BP <90 mmHg for >30 minutes OR mean arterial pressure <60 mmHg OR need for vasopressors to maintain these thresholds) AND clinical evidence of end-organ hypoperfusion—hypotension alone is insufficient for diagnosis. 1

Clinical Diagnostic Criteria

The diagnosis mandates meeting both components simultaneously 1:

Hypotension Component (must meet ≥1):

  • Systolic BP <90 mmHg sustained for >30 minutes 1
  • Mean arterial pressure <60 mmHg for >30 minutes 1
  • Requirement of vasopressors to maintain systolic BP ≥90 mmHg or MAP ≥60 mmHg 1

End-Organ Hypoperfusion (must have ≥1 sign):

  • Decreased mentation/altered mental status 1
  • Cold extremities with livedo reticularis 1
  • Urine output <30 mL/hour 1
  • Lactate >2 mmol/L 1
  • Metabolic acidosis 1
  • Mixed venous oxygen saturation (SvO₂) <65% 1

Hemodynamic Diagnostic Criteria

When invasive monitoring is available, cardiogenic shock diagnosis requires ALL three core parameters plus systolic BP <90 mmHg 1:

Core Hemodynamic Parameters:

  • Cardiac index <2.2 L/min/m² (some sources use <2.0 L/min/m²) 1
  • Pulmonary capillary wedge pressure (PCWP) >15 mmHg 1
  • Systolic BP <90 mmHg or mean BP <60 mmHg 1

Additional Hemodynamic Markers (supportive but not required):

  • Cardiac power output <0.6 W (calculated as [CO × MAP]/451) 1
  • Shock index >1.0 (heart rate/systolic BP) 1
  • Central venous pressure >15 mmHg 1, 2

Right Ventricular Shock-Specific Criteria:

  • Pulmonary artery pulsatility index [(PASP-PADP)/CVP] <1.0 1
  • CVP >15 mmHg 1
  • CVP-PCWP ratio >0.6 1

SCAI Staging Classification

The Society for Cardiovascular Angiography and Interventions provides a five-stage system for risk stratification 1, 2:

Stage A (At Risk):

  • Normal hemodynamics, normotensive (SBP >100 mmHg), normal perfusion, warm extremities 1
  • Normal renal function and lactate 1

Stage B (Beginning Shock/"Pre-shock"):

  • Elevated venous pressure, hypotension (SBP <90 mmHg, MAP <60 mmHg, or >30 mmHg drop from baseline) 1
  • Normal perfusion still present with warm extremities 1
  • Heart rate >100 bpm, cardiac index ≤2.2 L/min/m² 1
  • Preserved renal function, normal lactate, elevated BNP 1

Stage C (Classic Cardiogenic Shock):

  • Elevated venous pressure, hypotension, hypoperfusion present 1
  • Cold/ashen extremities with livedo, weak or nonpalpable pulses, altered mentation 1
  • Decreased urine output, respiratory distress 1
  • Impaired renal function, increased lactate and liver function tests 1
  • Cardiac index ≤2.2 L/min/m², PCWP >15 mmHg, cardiac power output <0.6 W 1

Stage D (Deteriorating):

  • Same as Stage C but worsening despite escalating vasopressors or mechanical circulatory support 1
  • Persistent or worsening laboratory values 1

Stage E (Extremis):

  • Cardiac arrest, refractory hypotension/hypoperfusion requiring CPR 1
  • Pulseless electrical activity (PEA), recurrent ventricular tachycardia/fibrillation 1
  • SBP only maintained with resuscitation 1

Critical Diagnostic Pitfalls

Common Mistake: Diagnosing shock based on hypotension alone

  • Hypotension is the primary clinical manifestation but insufficient for diagnosis without evidence of end-organ hypoperfusion 1
  • Always assess for clinical signs: mental status changes, cold extremities, oliguria, elevated lactate 1

Distinguishing from other shock types:

  • Cardiogenic shock: Elevated PCWP (>15 mmHg), elevated CVP, elevated systemic vascular resistance 1, 2
  • Hypovolemic shock: Low PCWP (<15 mmHg), low CVP, cold extremities but responds to fluid challenge 3
  • Distributive shock: Low systemic vascular resistance, normal or increased cardiac output initially, warm extremities 2

Hemodynamic monitoring considerations:

  • The 2022 ACC/AHA guidelines note there is no agreement on optimal hemodynamic monitoring method, including use of pulmonary artery catheters 1
  • Arterial line monitoring is recommended for continuous blood pressure assessment 1
  • Dynamic changes occur rapidly—continuous reassessment is essential 2

Fluid challenge before diagnosis:

  • A fluid challenge (>200 mL saline or Ringer's lactate over 15-30 minutes) should be attempted first if no overt fluid overload is present 1
  • This helps distinguish cardiogenic from hypovolemic shock 1

Immediate Assessment Requirements

When cardiogenic shock is suspected 1:

  • ECG immediately to identify acute coronary syndrome 1
  • Echocardiography immediately to assess cardiac function and identify mechanical complications 1
  • Invasive arterial monitoring for continuous blood pressure assessment 1
  • Transfer to tertiary care center with 24/7 cardiac catheterization and mechanical circulatory support capabilities 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hemodynamic Differentiation of Shock Types

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Criteria for Hypovolemic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.